Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 40.9B | 31.8B | 30.9B | 36.2B |
Cost of revenue | 7.7B | 5.1B | 4.5B | 6.1B |
Gross profit | 33.3B | 26.7B | 26.4B | 30.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 9.7B | 7.5B | 7.4B | 8.3B |
Other operating expenses | 13.5B | 11.9B | 12.5B | 12.9B |
Operating income | 4.8B | 1.5B | 980M | 3.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.1B | 1.0B | 980M | 950M |
Other income expense | — | — | — | — |
Pretax income | 4.7B | 830M | 730M | 1.9B |
Tax provision | 280M | 170M | 240M | 490M |
Net income | 4.4B | 660M | 490M | 1.5B |
Basic EPS | — | 3.3 | 2.5 | 7.5 |
Diluted EPS | — | 3.3 | 2.5 | 7.5 |
Basic average shares | — | 187.7M | 187.8M | 187.5M |
Diluted average shares | — | 187.7M | 187.8M | 187.5M |
EBITDA | 8.9B | 5.5B | 5.1B | 7.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | -40M | -50M | -30M | -40M |
Preferred stock dividends | 0 | 0 | 0 | 0 |